The strong presence of biotechnology companies, pharmaceutical manufacturers, and specialized cancer centers is supporting the US market. Increasing focus on personalized oncology and rare disease management is encouraging treatment innovation.
Market Overview
The Cutaneous T-Cell Lymphoma Treatment Market size was valued at US$ 520.80 million in 2025 and is expected to reach US$...